<?xml version="1.0" encoding="UTF-8"?>
<results title="testTrace">
 <result pre="respiratory signs and symptoms that progress rapidly to the asymptomatic" exact="infection" post="with atypical pneumonia and respiratory failure [[1], [2], [3],"/>
 <result pre="CoV infection. MERS-CoV, as well as SARS-CoV, promoted a serious" exact="infection" post="that required special care in intensive care units due"/>
 <result pre="ability to spread geographically, due to the fact that the" exact="infection" post="is asymptomatic in some cases. Although these viruses promote"/>
 <result pre="Guangdong Province, southeastern China. In the months following the primary" exact="infection" post="until its end in August 2003, there were 8422"/>
 <result pre="Zhongshan University. These 12 people were responsible for spreading the" exact="infection" post="to Singapore, Vietnam, Canada, Ireland, and the United States"/>
 <result pre="Ireland, and the United States - starting the chain of" exact="infection" post="in all these countries. According to WHO estimates, the"/>
 <result pre="Saudi Arabia who have jobs involving camels have a higher" exact="prevalence" post="of MERS-CoV antibodies than other individuals. These findings, associated"/>
 <result pre="these animals can be a source of spread of the" exact="infection" post="through human-animal contact [18]. According to the World Health"/>
 <result pre="Health Organization (WHO) in 2012, only 9 cases of MERS-CoV" exact="infection" post="were confirmed, including five deaths. The number of cases"/>
 <result pre="8b [8,44,45]. 5 Immune response to MERS-CoV, SARS-CoV and SARS-CoV-2" exact="infection" post="One of the characteristics among SARS-CoV, MERS-CoV, and SARS-CoV-2"/>
 <result pre="receptors by MERS-CoV [57,58]. The induction of immunosuppression throughout MERS-CoV" exact="infection" post="by promoting apoptosis of T lymphocytes was identified as"/>
 <result pre="signaling and activating T cells during the course of MERS-CoV" exact="infection" post="[60]. Ying et al. [58] observed that helper CD4+"/>
 <result pre="patients infected with MERS-CoV. Thus, it is suggested that MERS-CoV" exact="infection" post="promotes the induction of Th17 cytokines. These Th17 cytokines"/>
 <result pre="activity of recruiting neutrophils and monocytes to the site of" exact="infection" post="or inflammation and lead to the activation of other"/>
 <result pre="each virion and impair its entry into host cells. The" exact="detection" post="of these antibodies to MERS-CoV in human serum is"/>
 <result pre="tools of the adaptive response to MERS-CoV infection. However, serum" exact="detection" post="of anti-MERS-CoV antibodies occurs 14â€&quot;21 days after infection [63,64]."/>
 <result pre="However, serum detection of anti-MERS-CoV antibodies occurs 14â€&quot;21 days after" exact="infection" post="[63,64]. Antibody concentrations increase over time and can last"/>
 <result pre="long-term response is highly dependent on the severity of the" exact="infection" post="[65]. The anti-SARS-CoV antibody response can remain detectable for"/>
 <result pre="response can remain detectable for up to 24 months after" exact="infection" post="and then gradually decrease until it completely disappears 6"/>
 <result pre="then gradually decrease until it completely disappears 6 years after" exact="infection" post="[66,67]. Several HLA-A*02:01-restricted T lymphocytes that recognize epitopes of"/>
 <result pre="cells were found in a patient who recovered from SARS-CoV" exact="infection" post="within four years after the acute phase of the"/>
 <result pre="B lymphocytes to SARS-CoV decrease significantly after 1â€&quot;2 years of" exact="infection" post="[75]. The immunological findings to date are too preliminary"/>
 <result pre="[89]. A group of 12 pregnant women with a confirmed" exact="diagnosis" post="for SARS-CoV were analyzed, aged 27â€&quot;44 years in Hong"/>
 <result pre="children died, while the remaining cases did not have SARS-CoV" exact="infection" post="[2,93]. In the United States, in 2003, a study"/>
 <result pre="studied to define the risks and provide guidance for the" exact="treatment" post="of pregnant women infected with SARS-CoV [94]. An epidemiological"/>
 <result pre="It was the first occurrence of stillbirth during a MERS-CoV" exact="infection" post="and their consequences may help the surveillance and management"/>
 <result pre="by emergency cesarean section [95]. Another case of MERS coronavirus" exact="infection" post="in a pregnant woman described in South Korea resulted"/>
 <result pre="pregnant women to their fetuses. A case of neonatal SARS-CoV-2" exact="infection" post="in China with pharyngeal swabs was reported with a"/>
 <result pre="that there is evidence of a low risk of intrauterine" exact="infection" post="by vertical transmission of SARS-CoV-2 [104]. During the Hong"/>
 <result pre="be transmitted transplacentally from the mother to the baby the" exact="treatment" post="strategy for children with Covid-19 is based on the"/>
 <result pre="established drug. Although the population does not have a specific" exact="treatment" post="or vaccine for these diseases, it can be controlled"/>
 <result pre="controlled with a series of preventive measures and a drug" exact="treatment" post="regime [107,108] which may result in possible therapeutic treatment"/>
 <result pre="drug treatment regime [107,108] which may result in possible therapeutic" exact="treatment" post="option for the novel SARS-CoV-2 [77]. The treatment of"/>
 <result pre="possible therapeutic treatment option for the novel SARS-CoV-2 [77]. The" exact="treatment" post="of pregnant women for coronavirus is even more complicated,"/>
 <result pre="developed to treat HCV and especially children hospitalized for the" exact="treatment" post="of the respiratory syncytial virus (RSV). According to Kim"/>
 <result pre="Vero E6 cells, CQ was effective to inhibit the SARS-CoV-2" exact="infection" post="[123,124]. In addition 70 % of a patient group"/>
 <result pre="Azithromycin had no detectable viral load after 6 days of" exact="treatment" post="[126]. However, is important to show that this study"/>
 <result pre="of CQ or HCQ as an adjunct therapy in the" exact="treatment" post="of severe forms of COVID-19 in hospitalized patients [128]."/>
 <result pre="accessibility and previous studies of its effects in the malaria" exact="treatment" post="[103], the capacity to be ototoxic and retinotoxic in"/>
 <result pre="as a participant to the mammalian host defense against virus" exact="infection" post="[133]. The use of recombinant IFN inducers or IFN"/>
 <result pre="IFN inducers or IFN alone have been appointed as a" exact="treatment" post="option for MERS, supported by the fact that coronaviruses"/>
 <result pre="and also was used as an alternative to BCR-GLA-positive leukemia" exact="treatment" post="in pregnant women, with no evidence of increases to"/>
 <result pre="therefore MBL deficiency can be a factor of susceptibility to" exact="infection" post="[143]. The spike glycoprotein from SARS-CoV is a promising"/>
 <result pre="HIV, as gel and enema. However, to reach a preventive" exact="treatment" post="to SARS-CoV-2, the delivery systems of spike inhibitors needs"/>
 <result pre="death after emergency cesarean section. We believe that the coronaviruses" exact="infection" post="on pregnant can promote multiple disorders, such as shortness"/>
 <result pre="the epidemic and the challengesInt J Antimicrob Agents55202010592410.1016/j.ijantimicag.2020.105924 6PayneD.C.IblanI.AlqasrawiS.NsourM.A.RhaB.TohmeR.A.Stillbirth during" exact="infection" post="with Middle East respiratory syndrome coronavirusJ Infect Dis20920141870187210.1093/infdis/jiu068524474813 7MalikA.El"/>
 <result pre="East respiratory syndrome coronavirus (MERS-CoV)Available from:2019https://www.who.int/news-room/fact-sheets/detail/middle-east-respiratory-syndrome-coronavirus-(mers-cov) 21KeyaertsE.VijgenL.ChenL.MaesP.HedenstiernaG.Van RanstM.Inhibition of SARS-coronavirus" exact="infection" post="in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compoundInt"/>
 <result pre="follow-up surveysChinese J Cell Mol Immunol2032004322324 56JossetL.MenacheryV.D.GrajinskiL.E.AgnihothramS.SovaP.CarterV.S.Cell host response to" exact="infection" post="with novel human coronavirus EMC predicts potential antivirals and"/>
 <result pre="monocyte-derived dendritic cells modulates innate immune responseVirology454201419720510.1016/j.virol.2014.02.01824725946 58YingT.LiW.DimitrovD.S.Discovery of T-cell" exact="infection" post="and apoptosis by Middle East respiratory syndrome coronavirusJ Infect"/>
 <result pre="and IL-22 in asthma and infectionExpert Rev Respir Med812014254210.1586/17476348.2014.85416724325586 61MahallawiW.H.KhabourO.F.ZhangQ.MakhdoumH.M.SulimanB.A.MERS-CoV" exact="infection" post="in humans is associated with a pro-inflammatory Th1 and"/>
 <result pre="inflammationEmerg Microbes Infect2120131510.1038/emi.2013.58 63ParkW.B.RAPMPereraChoeP.G.LauE.H.Y.ChoiS.J.ChunJ.Y.Kinetics of serologic responses to MERS coronavirus" exact="infection" post="in humans, South KoreaEmerging Infect Dis21122015218610.3201/eid2112.15142126583829 64CormanV.M.AlbarrakA.M.OmraniA.S.AlbarrakA.M.FarahM.E.AlmasriM.Viral shedding and"/>
 <result pre="patients who recover from SARSJ Virol781120045612561810.1128/JVI.78.11.5612-5618.200415140958 69XuX.GaoX.M.Immunological responses against SARS-coronavirus" exact="infection" post="in humansCell Mol Immunol12200411912216212898 70YangL.T.PengH.ZhuZ.L.LiG.HuangZ.T.ZhaoZ.X.Long-lived effector/central memory T-cell responses"/>
 <result pre="and perinatal outcomeBMC Infect Dis16201610510.1186/s12879-016-1437-y26936356 83AssiriA.AbediG.R.MasriM.A.SaeedA.B.GerberS.I.WatsonJ.T.Middle East Respiratory syndrome coronavirus" exact="infection" post="during pregnancy: a report of 5 cases from Saudi"/>
 <result pre="Rep6223201348048323760190 85ChenH.GuoJ.WangC.LuoF.YuX.ZhangW.Clinical characteristics and intrauterine vertical transmission potential of COVID-19" exact="infection" post="in nine pregnant women: a retrospective review of medical"/>
 <result pre="during pregnancyJ Clin Invest127520171591159910.1172/JCI8749028459427 99AlfarajS.H.Al-TawfiqJ.A.MemishZ.A.Middle East Respiratory Syndrome Coronavirus (MERS-CoV)" exact="infection" post="during pregnancy: report of two cases &amp;amp; review of"/>
 <result pre="Pathol Lab Med202010.5858/arpa.2020-0901-SA0: null 103WangS.GuoL.ChenL.LiuW.CaoY.ZhangJ.A case report of neonatal COVID-19" exact="infection" post="in ChinaClin Infect Dis202010.1093/cid/ciaa225 104FanC.LeiD.FrangC.LiC.WangM.LiuY.Perinatal Transmission of COVID-19 Associated"/>
 <result pre="and neonate: what neonatologist need to knowJ Med Virol92202056456710.1002/jmv.2574032115733 107MustafaS.BalkhyH.GabereM.N.Current" exact="treatment" post="options and the role of peptides as potential therapeutic"/>
 <result pre="SARS coronavirus and MERS coronavirusâ€&quot;A possible reference for coronavirus Diseaseâ€�19" exact="treatment" post="optionJ Med Virol92202055656310.1002/jmv.2572932104907 109ArabiY.M.ShalhoubS.MandourahY.Al-HameedF.Al-OmariA.QasimE.A.Ribavirin and interferon therapy for critically"/>
 <result pre="Infect Dis70920191837184410.1093/cid/ciz544 110MomattinH.Al-AliA.Y.Al-TawfiqJ.A.A Systematic Review of therapeutic agents for the" exact="treatment" post="of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV)Travel Med"/>
 <result pre="Coronavirus (MERS-CoV)Travel Med Infect Dis30201991810.1016/j.tmaid.2019.06.01231252170 111WitE.FeldmannF.CroninJ.JordanR.OkumuraA.ThomasT.Prophylactic and therapeutic remdesivir (GS-5734)" exact="treatment" post="in the rhesus macaque model of MERS-CoV infectionProc Natl"/>
 <result pre="(MERS) coronavirus contamination in air and surrounding environment in MERS" exact="isolation" post="wardsRev Infect Dis633201636336910.1093/cid/ciw239 114ArabiY.M.AsiriA.Y.AssiriA.M.JokhdarH.A.A.AlothmanA.BalkhyH.H.Treatment of Middle East respiratory syndrome"/>
 <result pre="systematic review of SARS-CoV therapyInt J Infect Dis17102013e792e79810.1016/j.ijid.2013.07.00223993766 116ChangC.K.JeyachandranS.HuN.J.LiuC.L.LinS.Y.WangY.S.Structure-based virtual" exact="screening" post="and experimental validation of the discovery of inhibitors targeted"/>
 <result pre="ProteasesbioRxiv0131202092969510.1101/2020.01.31.929695 119Dieterich, DT. Method of treating anemia caused by ribavirin" exact="treatment" post="of hepatitis C using erythropoietin alpha. U.S. Patent 2019;"/>
 <result pre="drugs in human monocyte-derived antigen-presenting cellsPLoS One132018e01948610.1371/journal.pone.0194868 125MoY.FisherD.A review of" exact="treatment" post="modalities for Middle East respiratory syndromeJ Antimicrob Chemother711220163340335010.1093/jac/dkw33827585965 126GautretP.LagierJ.C.ParolaP.HoangV.T.MeddebL.MailheM.Hydroxychloroquine"/>
 <result pre="East respiratory syndromeJ Antimicrob Chemother711220163340335010.1093/jac/dkw33827585965 126GautretP.LagierJ.C.ParolaP.HoangV.T.MeddebL.MailheM.Hydroxychloroquine and azithromycin as a" exact="treatment" post="of COVID-19: results of an open-label non-randomized clinical trialJ"/>
 <result pre="Med Health3202017 129PauqueL.MagnardP.Retinal degeneration in two children following preventive antimalarial" exact="treatment" post="of the mother during pregnancyBull Soc Ophtalmol Fr6919694664675403305 130KaplanY.C.OzsarfatiJ.NickelC.KorenG.Reproductive"/>
 <result pre="134ChannappanavarR.FehrA.R.ZhengJ.Wohljord-LenaneC.AbrahanteJ.E.MackM.IFN-I response timing relative to virus replication determines MERS coronavirus" exact="infection" post="outcomesJ Clin Invest1299201910.1172/JCI126363 135HabibA.M.G.AliM.A.E.ZouaouiB.R.TahaM.A.H.MohammedB.S.SaquibN.Clinical outcomes among hospital patients with"/>
 <result pre="145HaagmansB.L.Van Den BrandJ.M.RajV.S.VolzA.WohkseinP.SmitsS.L.An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV" exact="infection" post="in dromedary camelsScience35162682016778110.1126/science.aad128326678878"/>
</results>
